First Trust Nasdaq Pharmaceuticals ETF
FTXH
7 hedge funds and large institutions have $601K invested in First Trust Nasdaq Pharmaceuticals ETF in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
17% more funds holding
Funds holding: 6 → 7 (+1)
31.76% less ownership
Funds ownership: 59.84% → 28.09% (-32%)
50% less capital invested
Capital invested by funds: $1.2M → $601K (-$597K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$492K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$16.1K |
| 3 |
FAAS
First Allied Advisory Services
San Diego,
California
|
+$2.06K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.13M |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
-$4K |
| 3 |
RAM
Riggs Asset Management
Dallas,
Pennsylvania
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $512K | +$492K | +23,910 | New |
|
2
Bank of America
Charlotte,
North Carolina
| $43K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $17K | +$16.1K | +784 | New |
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $12K | – | – | – |
|
|
LTFS
5
Ladenburg Thalmann Financial Services
Miami,
Florida
| $10K | – | – | – |
|
|
APA
6
American Portfolios Advisors
Holbrook,
New York
| $5.35K | +$5.15K | +250 | New |
|
|
FAAS
7
First Allied Advisory Services
San Diego,
California
| $2K | +$2.06K | +100 | New |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.13M | -56,488 | Closed |
|
|
IA
9
IFP Advisors
Tampa,
Florida
| – | -$4K | -200 | Closed |
|
|
RAM
10
Riggs Asset Management
Dallas,
Pennsylvania
| – | -$2K | -114 | Closed |
|
FTXH Hedge Fund Activity: Q4 2017 in Review
7 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in First Trust Nasdaq Pharmaceuticals ETF (FTXH) for Q4 2017, worth a combined $601K — down 50% from $1.2M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FTXH positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $492K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.13M sold.
- 7 institutional investors held First Trust Nasdaq Pharmaceuticals ETF (FTXH) as of Q4 2017, up from 6 in Q3 2017.
- Funds reported $601K of First Trust Nasdaq Pharmaceuticals ETF stock for Q4 2017, down 50% quarter-over-quarter.
- 4 funds opened new First Trust Nasdaq Pharmaceuticals ETF positions in Q4 2017 and 3 closed out, a net change of +1 holder.
- The largest First Trust Nasdaq Pharmaceuticals ETF buyer in Q4 2017 was Jane Street, an estimated $492K added.
- The largest First Trust Nasdaq Pharmaceuticals ETF seller in Q4 2017 was Susquehanna International Group, an estimated $1.13M sold.
Based on aggregated 13F filings for Q4 2017.